{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:42:36Z","timestamp":1776462156748,"version":"3.51.2"},"reference-count":6,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1002\/ajh.24913","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T08:32:53Z","timestamp":1506069173000},"source":"Crossref","is-referenced-by-count":15,"title":["The Eutos long\u2010term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials"],"prefix":"10.1002","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-4406","authenticated-orcid":false,"given":"Matteo","family":"Molica","sequence":"first","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Canichella","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Alunni Fegatelli","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioia","family":"Colafigli","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Massaro","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-862X","authenticated-orcid":false,"given":"Roberto","family":"Latagliata","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-6162","authenticated-orcid":false,"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology Policlinico Umberto 1, Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.261"},{"key":"e_1_2_2_3_1","article-title":"The Eutos long\u2010term survival score is predictive for response and outcome in CML patients treated frontline with Nilotinib\u2010based regimens","author":"Castagnetti F","year":"2016","journal-title":"Abstract."},{"key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood.V114.22.1126.1126","article-title":"International randomized study of interferon vs STI571 (IRIS) 8\u2010year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML\u2010CP) treated with imatinib","volume":"114","author":"Deininger M","year":"2009","journal-title":"Blood."},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095158"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.4.789.789"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.11.850"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:29:16Z","timestamp":1695572956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1002\/ajh.24913"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24913","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}